Search results
Results from the WOW.Com Content Network
Famotidine, sold under the brand name Pepcid among others, is a histamine H 2 receptor antagonist medication that decreases stomach acid production. [4] It is used to treat peptic ulcer disease, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. [4] It is taken by mouth or by injection into a vein. [4] It begins working within an ...
Cimetidine was the prototypical histamine H 2 receptor antagonist from which later drugs were developed. Cimetidine was the culmination of a project at Smith, Kline & French (SK&F; now GlaxoSmithKline) by James W. Black, C. Robin Ganellin, and others to develop a histamine receptor antagonist that would suppress stomach acid secretion.
Epinephrine vial 1 mg (Adrenalin). Epinephrine is used to treat a number of conditions, including cardiac arrest, anaphylaxis, and superficial bleeding. [25] It has been used historically for bronchospasm and low blood sugar, but newer treatments for these that are selective for β 2 adrenoceptors, such as salbutamol, are preferred.
Here's what experts say about using antibiotics to treat the common cold — and why you can still catch one in the summer. ... Schaffner points to older research in which people were divided into ...
Mast cell activation syndrome (MCAS) is a term referring to one of two types of mast cell activation disorder (MCAD); the other type is idiopathic MCAD. [1] MCAS is an immunological condition in which mast cells, a type of white blood cell, inappropriately and excessively release chemical mediators, such as histamine, resulting in a range of chronic symptoms, sometimes including anaphylaxis or ...
These types of drugs are widely used to treat them. However, the study does not state that these classes of acid-suppressing medications cause migraine attacks or severe headaches.
The American Heart Association reported a major spike in interest in hands-only CPR in the days following Hamlin’s cardiac arrest, which could lead to greater bystander intervention and higher ...
The number of people who get anaphylaxis is 4–100 per 100,000 persons per year, [10] [54] with a lifetime risk of 0.05–2%. [55] About 30% of affected people get more than one attack. [ 54 ] Exercise-induced anaphylaxis affects about 1 in 2000 young people.